Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor

Molecular Endocrinology

Volumn 14, Issue 6, 2000, Pages 795-804

  Elbaz, N ^a   Bedecs, K ^a   Masson, M ^a   Sutren, M ^a   Strosberg, A D ^a   Nahmias, C ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHO CELL; CONTROLLED STUDY; ENZYME INACTIVATION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034464025     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.6.0488     Document Type: Article

References (74)

1. The angiotensin AT2 receptor: Searching for signal-transduction and physiological function
2. Receptors and their classification: Focus on angiotensin II and the AT2 receptor
3. Signaling mechanism of the AT2 angiotensin II receptor: Cross-talk between AT1 and AT2 receptors in cell growth
4. Signal transduction from the angiotensin II AT2 receptor
5. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice
6. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
7. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects
8. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1 B receptors for angiotensin II
9. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor
10. Angiotensin II type 2 receptor blockade amplities the early signals of cardiac growth response to angiotensin II in hypertrophied hearts
11. Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth
12. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury
13. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer
14. The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats
15. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men
16. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors
17. Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: Role of the AT2 receptor
18. Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells
19. Angiotensin II type 2 receptor mediates programmed cell death
20. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide
21. Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain
22. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
23. The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells
24. ANG II AT1 and AT2 receptors both inhibit bFGF-induced proliferation of bovine adrenocortical cells
25. Angiotensin II signal transduction in vascular smooth muscle: Pathways activated by specific tyrosine kinases
26. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases
27. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
28. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors
29. Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes
30. The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase
31. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent activity
32. A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells
33. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis
34. Role of transactivation of the EGF receptor in signalling by Gprotein-coupled receptors
35. Signal charadteristics of G protein-transactivated EGF receptor
36. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of pro-HB-EGF
37. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells
38. Calcium-dependent epidermal growth factor receptor trans-activation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
39. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: Thrombin and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate I and insulin-like growth factor receptor
40. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein tyrosine phosphatase 1D in vascular smooth muscle cells
41. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart
42. Cross-talk between the insulin and angiotensin signaling systems
43. Protein kinase C isoforms β1 and β2 inhibit the tyrosine kinase activity of the insulin receptor
44. Protein kinase C isoforms α, δ and θ require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293)
45. A family of proteins that inhibit signalling through tyrosine kinase receptors
46. A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion
47. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin
48. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation
49. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction
50. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling
51. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp
52. Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction
53. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation
54. Identification of major binding proteins and substrates for the SH2-containing protein phosphatase SHP-1 in macrophages
55. High expression of inhibitory receptor SHPS-1 and its association with protein tyrosine phosphatase SHP-1 in macrophages
56. sst2 Somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1
57. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
58. Differential sensitivity of the insulin-receptor kinase to thiol and oxidizing agents in the absence and presence of insulin
59. Sulphydryl agents modulate insulin-and epidermal growth factor (EGF) receptor kinase via reaction with intracellular receptor domains: Differential effects on basal versus activated receptors
60. Redox priming of the insulin receptor β-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation
61. Epidermal growth factor stimulates the tyrosine phosphorylation of SHPS- 1 and association of SHPS-1 with SHP-2, a SH2 domain-containing protein tyrosine phosphatase
62. Lysophosphatidic acid-induced association of SHP-2 with SHPS-l: Roles of RHO, FAK, and a SRC family kinase
63. Integrin-mediated tyrosine phosphorylation of SHPS-1 and its association with SHP-2. Roles of Fak and Src family kinases
64. Regulation of early events in integrin signaling by protein tyrosine phosphatase SHP-2
65. Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus
66. Insulin resistance, hyperinsulinemia, and hypertension: Causes, consequences or merely correlations?
67. The interaction of insulin and angiotensin on the regulation of human neuroblastoma cell growth
68. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: Effects of AT1/AT2 antagonists
69. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular smooth muscle cells
70. Insulin is required for angiotensin II-mediated hypertrophy of smooth muscle cells
71. Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells
72. Isoproterenol inhibits insulin-stimulated tyrosine phosphorylation of the insulin receptor without increasing its serine/threonine phosphorylation
73. Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells
74. Characterization of angiotensin II receptor subtypes in pancreatic acinar AR42J cells